jamanetwork.com/journals/jamanetworkopen/fullarticle/2789423
This is a study that tracks young people for a 12 month period only. There is no follow up after.
Were you able to track the number of participants who had therapy for their mental health in this study at all?
I could not see this but I am only on a small screen and it is difficult to analyse this in as much depth as I like too.
Because I did not read any adjustments made around that.
Now, I know hearache you have been told before about the specific increased health risks of puberty blockers and testosterone on the female body.
The life limiting, too often life shortening negative side effects that show up much later than 12 months down the treatment path.
Is there a reason you keep avoiding acknowledging this?
Because this will start affecting participant’s mental health in the longer term. Including the significant symptoms of menopause those females will experience.
Back to this study.
It is also concerning that 30% did not do the questionnaire and as the questionnaire was only administered voluntarily I consider the results to be discussion started only and not a robust study to use to inform guidance in any way.
If this was a study of clinician led mental health surveys with a review of notes, it may be much more useable than it is. As it is, this is just another biased piece of work that seems to ignore the personal accounts of clinicians, including the Tavistock.
By the way, remember there was also a study done by another Ivy League university that declared a similar outcome … only to have to retract its conclusions less than a year later after clinicians and other researchers pointed out the errors in it.
It showed no or too little overall improvement to warrant the conclusions drawn.
So this paragraph is also important.
it is important to note that we observed a transient and nonsignificant worsening in mental health outcomes in the first several months of care among all participants and that these outcomes subsequently returned to baseline by 12 months. This is consistent with findings from a 2020 study36 in an academic medical center in the northwestern US that observed no change in TNB adolescents’ GAD-7 or PHQ-9 scores from intake to first follow-up appointment, which occurred a mean of 4.7 months apart. Given that receipt of PBs or GAHs was associated with protection against depression and suicidality in our study, it could be that delays in receipt of medications is associated with initially exacerbated mental health symptoms that subsequently improve. It is also possible that mental health improvements associated with receiving these interventions may have a delayed onset, given the delay in physical changes after starting GAHs.
And this is important too.
This was a clinical sample of TNB youths, and there was likely selection bias toward youths with supportive caregivers who had resources to access a gender-affirming care clinic. Family support and access to care are associated with protection against poor mental health outcomes, and thus actual rates of depression, anxiety, and suicidality in nonclinical samples of TNB youths may differ.
I am sure others will be along to analyse the study. But it doesn’t seem to be very robust or useful to me.
Happy to see others who have gone through it show me why my concerns are not warranted though. I am only on a small screen as I said so I could be missing information.